Literature DB >> 23062737

A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.

Anne L Hotard1, Fyza Y Shaikh, Sujin Lee, Dan Yan, Michael N Teng, Richard K Plemper, James E Crowe, Martin L Moore.   

Abstract

We describe the first example of combining bacterial artificial chromosome (BAC) recombination-mediated mutagenesis with reverse genetics for a negative strand RNA virus. A BAC-based respiratory syncytial virus (RSV) rescue system was established. An important advantage of this system is that RSV antigenomic cDNA was stabilized in the BAC vector. The RSV genotype chosen was A2-line19F, a chimeric strain previously shown to recapitulate in mice key features of RSV pathogenesis. We recovered two RSV reporter viruses, one expressing the red fluorescent protein monomeric Katushka 2 (A2-K-line19F) and one expressing Renilla luciferase (A2-RL-line19F). As proof of principle, we efficiently generated a RSV gene deletion mutant (A2-line19FΔNS1/NS2) and a point mutant (A2-K-line19F-I557V) by recombination-mediated BAC mutagenesis. Together with sequence-optimized helper expression plasmids, BAC-RSV is a stable, versatile, and efficient reverse genetics platform for generation of a recombinant Pneumovirus.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062737      PMCID: PMC3492879          DOI: 10.1016/j.virol.2012.09.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome.

Authors:  F Almazán; J M González; Z Pénzes; A Izeta; E Calvo; J Plana-Durán; L Enjuanes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Functional genetic and biophysical analyses of membrane disruption by human adenovirus.

Authors:  Crystal L Moyer; Christopher M Wiethoff; Oana Maier; Jason G Smith; Glen R Nemerow
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

3.  Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.

Authors:  Anna R Kwilas; Mark A Yednak; Liqun Zhang; Rachael Liesman; Peter L Collins; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  Independent structural domains in paramyxovirus polymerase protein.

Authors:  Melanie Dochow; Stefanie A Krumm; James E Crowe; Martin L Moore; Richard K Plemper
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

5.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  Reverse genetics plasmid for cloning unstable influenza A virus gene segments.

Authors:  Bin Zhou; Greta Jerzak; Derek T Scholes; Matthew E Donnelly; Yan Li; David E Wentworth
Journal:  J Virol Methods       Date:  2011-02-03       Impact factor: 2.014

7.  Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice.

Authors:  Kate L Stokes; Michael H Chi; Kaori Sakamoto; Dawn C Newcomb; Michael G Currier; Matthew M Huckabee; Sujin Lee; Kasia Goleniewska; Carla Pretto; John V Williams; Anne Hotard; Taylor P Sherrill; R Stokes Peebles; Martin L Moore
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

8.  Far-red fluorescent tags for protein imaging in living tissues.

Authors:  Dmitry Shcherbo; Christopher S Murphy; Galina V Ermakova; Elena A Solovieva; Tatiana V Chepurnykh; Aleksandr S Shcheglov; Vladislav V Verkhusha; Vladimir Z Pletnev; Kristin L Hazelwood; Patrick M Roche; Sergey Lukyanov; Andrey G Zaraisky; Michael W Davidson; Dmitriy M Chudakov
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

9.  A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction.

Authors:  Martin L Moore; Michael H Chi; Cindy Luongo; Nicholas W Lukacs; Vasiliy V Polosukhin; Matthew M Huckabee; Dawn C Newcomb; Ursula J Buchholz; James E Crowe; Kasia Goleniewska; John V Williams; Peter L Collins; R Stokes Peebles
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 10.  Back to BAC: the use of infectious clone technologies for viral mutagenesis.

Authors:  Robyn N Hall; Joanne Meers; Elizabeth Fowler; Timothy Mahony
Journal:  Viruses       Date:  2012-02-03       Impact factor: 5.048

View more
  74 in total

1.  Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response.

Authors:  Dan Yan; Stefanie A Krumm; Aiming Sun; David A Steinhauer; Ming Luo; Martin L Moore; Richard K Plemper
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

2.  A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.

Authors:  Christina A Rostad; Christopher C Stobart; Brian E Gilbert; Ray J Pickles; Anne L Hotard; Jia Meng; Jorge C G Blanco; Syed M Moin; Barney S Graham; Pedro A Piedra; Martin L Moore
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

3.  Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice.

Authors:  Leslie van der Fits; Renske Bolder; Marjolein Heemskerk-van der Meer; Joke Drijver; Yolinda van Polanen; Jan Serroyen; Johannes P M Langedijk; Hanneke Schuitemaker; Eirikur Saeland; Roland Zahn
Journal:  NPJ Vaccines       Date:  2020-06-12       Impact factor: 7.344

4.  Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex.

Authors:  Alberto Jiménez-Somarribas; Shuli Mao; Jeong-Joong Yoon; Marco Weisshaar; Robert M Cox; Jose R Marengo; Deborah G Mitchell; Zachary P Morehouse; Dan Yan; Ivan Solis; Dennis C Liotta; Michael G Natchus; Richard K Plemper
Journal:  J Med Chem       Date:  2017-03-13       Impact factor: 7.446

5.  Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.

Authors:  A Leemans; M De Schryver; W Van der Gucht; A Heykers; I Pintelon; A L Hotard; M L Moore; J A Melero; J S McLellan; B S Graham; L Broadbent; U F Power; G Caljon; P Cos; L Maes; P Delputte
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

6.  Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.

Authors:  Srirupa Chatterjee; Priya Luthra; Ekaterina Esaulova; Eugene Agapov; Benjamin C Yen; Dominika M Borek; Megan R Edwards; Anuradha Mittal; David S Jordan; Parameshwar Ramanan; Martin L Moore; Rohit V Pappu; Michael J Holtzman; Maxim N Artyomov; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  Nat Microbiol       Date:  2017-06-30       Impact factor: 17.745

7.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

8.  Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.

Authors:  Crystal W Burke; Mei Li; Julia L Hurwitz; Peter Vogel; Charles J Russell
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

Review 9.  Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.

Authors:  Darryl Falzarano; Allison Groseth; Thomas Hoenen
Journal:  Antiviral Res       Date:  2014-01-23       Impact factor: 5.970

10.  Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.

Authors:  Dan Yan; Sujin Lee; Vidhi D Thakkar; Ming Luo; Martin L Moore; Richard Karl Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.